Literature DB >> 12716809

Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring.

Cyrus Desouza1, Holger Salazar, Benjamin Cheong, Joseph Murgo, Vivian Fonseca.   

Abstract

OBJECTIVE: In some studies intensive diabetes treatment in patients with type 2 diabetes may be associated with increased cardiovascular events. It is not clear whether these events are related to hypoglycemic episodes. To determine whether episodes of hypoglycemia were more likely to be associated with cardiac ischemia than normoglycemia or hyperglycemia, we carried out a study in 21 patients with coronary artery disease (CAD) and type 2 diabetes treated with insulin who had good glycemic control. RESEARCH DESIGN AND METHODS: We carried out 72-h continuous glucose monitoring along with simultaneous cardiac Holter monitoring for ischemia. Patients also recorded symptoms of cardiac ischemia (chest pain) and symptoms of hypoglycemia.
RESULTS: Satisfactory continuous glucose monitoring system recordings were obtained in 19 patients. We recorded 54 episodes of hypoglycemia (blood glucose <70 mg/dl; 26 of these were symptomatic) and 59 episodes of hyperglycemia (blood glucose >200 mg/dl; none symptomatic). Of the 54 episodes of hypoglycemia, 10 were associated with symptoms of chest pain, during 4 of which electrocardiographic abnormalities were documented. In contrast, only 1 episode of chest pain occurred during 59 episodes of hyperglycemia. No chest pain or electrocardiographic abnormalities occurred when the blood glucose was within the normal range. The difference between the frequency of ischemia during hypoglycemia and the frequency during both hyperglycemia and normoglycemia was statistically significant (P < 0.01). There were 50 episodes during which the blood glucose changed by >100 mg over a 60-min period, and ischemic symptoms occurred during 9 of these episodes (P < 0.01 compared with stable normoglycemia or hyperglycemia).
CONCLUSIONS: Hypoglycemia is more likely to be associated with cardiac ischemia and symptoms than normoglycemia and hyperglycemia, and it is particularly common in patients who experience considerable swings in blood glucose. These data may be important in the institution of insulin treatment and attempting near-normal glycemia in patients with known CAD. Further research is needed to determine strategies to prevent ischemia associated with hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716809     DOI: 10.2337/diacare.26.5.1485

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  112 in total

1.  Prediction and prevention of treatment-related inpatient hypoglycemia.

Authors:  Michael B Elliott; Stephen J Schafers; Janet B McGill; Garry S Tobin
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

Review 2.  Glycemic control and weight reduction without causing hypoglycemia: the case for continued safe aggressive care of patients with type 2 diabetes mellitus and avoidance of therapeutic inertia.

Authors:  Stanley S Schwartz; Benjamin A Kohl
Journal:  Mayo Clin Proc       Date:  2010-11-24       Impact factor: 7.616

3.  Association of the average rate of change in HbA1c with severe adverse events: a longitudinal evaluation of audit data from the Bavarian Disease Management Program for patients with type 2 diabetes mellitus.

Authors:  Florian C Bonke; Ewan Donnachie; Antonius Schneider; Michael Mehring
Journal:  Diabetologia       Date:  2015-10-30       Impact factor: 10.122

4.  Elective percutaneous coronary intervention: the relationship between preprocedural blood glucose levels and periprocedural myocardial injury.

Authors:  Mohsen Madani; Keivan Alizadeh; Sepideh Parchami Ghazaee; Abbas Zavarehee; Seifollah Abdi; Farshad Shakerian; Negar Salehi; Ata Firouzi
Journal:  Tex Heart Inst J       Date:  2013

Review 5.  Diabetes and Cardiovascular Disease: Is intensive glucose control beneficial or deadly? Lessons from ACCORD, ADVANCE, VADT, UKPDS, PROactive, and NICE-SUGAR.

Authors:  Guntram Schernthaner
Journal:  Wien Med Wochenschr       Date:  2010-01

6.  What's wrong with too low? Is hypoglycemia a marker or a cause of CVD and mortality risk?

Authors:  Anthony L McCall
Journal:  Curr Diab Rep       Date:  2011-04       Impact factor: 4.810

7.  Starting glargine in insulin-naïve type 2 diabetic patients based on body mass index is safe.

Authors:  Denise R Franco; Juliana Baptista; Fatima Rm Abreu; Risoneide B Batista; Freddy G Eliaschewitz
Journal:  World J Diabetes       Date:  2014-02-15

Review 8.  Coronary artery disease and diabetes mellitus.

Authors:  Doron Aronson; Elazer R Edelman
Journal:  Cardiol Clin       Date:  2014-06-10       Impact factor: 2.213

Review 9.  Impact of hypoglycemia in hospitalized patients.

Authors:  Michelle Carey; Laura Boucai; Joel Zonszein
Journal:  Curr Diab Rep       Date:  2013-02       Impact factor: 4.810

10.  Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals.

Authors:  Nino Gogitidze Joy; Maka S Hedrington; Vanessa J Briscoe; Donna B Tate; Andrew C Ertl; Stephen N Davis
Journal:  Diabetes Care       Date:  2010-07       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.